From GlobeNewswire:

Repligen Corporation (NASDAQ:RGEN) will report its Q4 2023 financial results on February 21, 2024. A press release will precede the 8:30 a.m. ET conference call. Toll-free dial-in is (844) 274-3999. A webcast will be available at the Investor Relations section of the company’s website. Repligen develops bioprocessing technologies and systems for manufacturing biological drugs. They are headquartered in Waltham, Massachusetts. Their corporate website is www.repligen.com.



Read more: Repligen to Report Fourth Quarter and Full Year 2023